Expert Interviews

Todd W. Frieze, MD, concludes this series discussing differences in benign vs cancerous tumors and key final takeaways.

Todd W. Frieze, MD, highlights the various ways to accurately assess patient thyroid hormone levels and the general guidelines on patient surveillance.

Todd W. Frieze, MD, discusses various suppression therapy approaches for patients with hypothyroidism and thyroid cancer.

Alex Tessnow, MD, concludes this series with key final takeaways.

Alex Tessnow, MD, reviews treatment approaches for elderly patients with hypothyroidism.

Alex Tessnow, MD, discusses the common symptoms and red flags associated with hypothyroidism in elderly patients.

Alex Tessnow, MD, highlights the variability of hypothyroidism among elderly patients.

Dr Turner reviews the profile of the individual who is most likely to benefit from lecanemab therapy.

Georgetown University memory disorders expert R Scott Turner, PhD, MD, reviews the science behind approval of lecanemab for monthly maintenance dosing of lecanemab.

The revolutionary medications are the first new treatments for Alzheimer disease to be approved in more than 20 years and the first-ever disease-modifying drugs.